Case series of cerebral infarction with Trousseau's syndrome associated with malignant gynecological tumors

Ishikawa,Masako; Nakayama,Kentaro; Ishibashi,Tomoka; Sato,Emi; Nakamura,Kohei; Katagiri,Hiroshi; Kyo,Satoru

doi:10.3892/mco.2016.888

July-2016 Volume 5 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

July-2016 Volume 5 Issue 1

Full Size Image

Article

Case series of cerebral infarction with Trousseau's syndrome associated with malignant gynecological tumors

Authors:
- Masako Ishikawa
- Kentaro Nakayama
- Tomoka Ishibashi
- Emi Sato
- Kohei Nakamura
- Hiroshi Katagiri
- Satoru Kyo
View Affiliations / Copyright

Affiliations: Department of Obstetrics and Gynecology, Shimane University School of Medicine, Izumo, Shimane 6938501, Japan
Pages: 138-142
|
Published online on: May 6, 2016

https://doi.org/10.3892/mco.2016.888
Expand metrics +

Abstract

The association between neoplastic disease and thromboembolic disorders was first recognized by Trousseau in 1865. Blood coagulation abnormalities have been reported in the majority of patients with cancer, including those with ovarian carcinoma. However, Trousseau's syndrome (TS) has rarely been reported in women with ovarian carcinoma. We herein report a case series of TS, notably in the brain, in association with gynecological malignant disease, and emphasize the difficulties associated with the management of these thromboembolic effects. The aim of this study was to present our experience with 5 TS patients whose condition was effectively controlled through treatment of the primary malignant disease. Therefore, we suggest that patients with TS may be cured by tumor resection, even if they have severe thromboembolic disease, such as cerebral or pulmonary infarction.

View Figures

View References

1	Trousseau A: Phlegmasia alba dolens. Lectures on Clinical Medicine, delivered at the Hotel-Dieu, Paris. 5:(London, England). New Sydenham Society. 281–332. 1865.
2	Sack GH Jr, Levin J and Bell WR: Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: Clinical, pathophysiologic, and therapeutic features. Medicine (Baltiinore). 56:1–37. 1977. View Article : Google Scholar
3	Viselli AL, Feuer GA and Granai CO: Lower limb ischemic venous thrombosis in patients with advanced ovarian carcinoma. Gynecol Oncol. 49:262–265. 1993. View Article : Google Scholar : PubMed/NCBI
4	Planner RS, O'Sullivan EF, Campbell JJ and Ball DL: The hypercoagulable state and pulmonary embolism in patients with ovarian carcinoma. Aust N Z J Obstet Gynaecol. 18:209–212. 1978. View Article : Google Scholar : PubMed/NCBI
5	Ito S, Yoshitomi H, Pak M, Kawahara H, Oshima T, Ito S, Watanabe N, Sato H, Adachi T, Takeda M, et al: Trousseau syndrome with nonbacterial thrombotic endocarditis in a patient with uterine cancer. Intern Med. 52:1353–1358. 2013. View Article : Google Scholar : PubMed/NCBI
6	Shao B, Wahrenbrock MG, Yao L, David T, Coughlin SR, Xia L, Varki A and McEver RP: Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome. Blood. 118:4015–4023. 2011. View Article : Google Scholar : PubMed/NCBI
7	Levitan N, Dowlati A, Remick SC, Tahsildar HI, Sivinski LD, Beyth R and Rimm AA: Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims date. Medicine (Baltimore). 78:285–291. 1999. View Article : Google Scholar : PubMed/NCBI
8	Vernon S: Trousseau's syndrome: Thrombophlebitis with carcinoma. J Abdom Surg. 3:137–138. 1961.PubMed/NCBI
9	Cestari DM, Weine DM, Panageas KS, Segal AZ and DeAngelis LM: Stroke in patients with cancer: Incidents and etiology. Neurology. 62:2025–2030. 2004. View Article : Google Scholar : PubMed/NCBI
10	Zhang YY, Chan DK, Cordato D, Shen Q and Sheng AZ: Stroke risk factor, pattern and outcome in patients with cancer. Acta Neurol Scand. 114:378–383. 2006. View Article : Google Scholar : PubMed/NCBI
11	Bell WR, Starksen NF, Tong S and Porterfield JK: Trousseau's syndrome. Devastating coagulopathy in the absence of heparin. Am J Med. 79:423–430. 1985. View Article : Google Scholar : PubMed/NCBI
12	Krauth D, Holden A, Knapic N, Liepman M and Ansell J: Safety and efficacy of long-term oral anticoagulation in cancer patients. Cancer. 59:983–985. 1987. View Article : Google Scholar : PubMed/NCBI
13	Walsh-McMonagle D and Green D: Low-molecular-weight heparin in the management of Trousseau's syndrome. Cancer. 80:649–655. 1997. View Article : Google Scholar : PubMed/NCBI
14	Meyer G, Marjanovic Z, Valcke J, Lorcerie B, Gruel Y, Solal-Celigny P, Le Maignan C, Extra JM, Cottu P and Farge D: Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: A randomized controlled study. Arch Intern Med. 162:1729–1735. 2002. View Article : Google Scholar : PubMed/NCBI
15	Levine MN: Managing thromboembolic disease in the cancer patient: Efficacy and safety of antithrombotic treatment options in patients with cancer. Cancer Treat Rev. 28:145–149. 2002. View Article : Google Scholar : PubMed/NCBI
16	Castelli R, Porro F and Tarsia P: The heparins and cancer: Review of clinical trials and biological properties. Vasc Med. 9:205–213. 2004. View Article : Google Scholar : PubMed/NCBI
17	Zacharski LR and Loynes JT: Low-molecular-weight heparin in oncology. Anticancer Res. 23:2789–2793. 2003.PubMed/NCBI
18	McCart GM and Kayser SR: Therapeutic equivalency of low-molecular-weight heparins. Ann Pharmacother. 36:1042–1057. 2002. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Case series of cerebral infarction with Trousseau's syndrome associated with malignant gynecological tumors

This article is mentioned in:

Abstract

Figure 1

Figure 2

Related Articles